Yalan Yu
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- RNA modifications and cancer 4
- Circular RNAs in diseases 3
-
- Acute Myeloid Leukemia Research 3
- Multiple Myeloma Research and Treatments 2
- Co-authors
- Jiancheng Tu (4 shared papers)Xuelan Zuo (6 shared papers)Sanyun Wu (6 shared papers)Ping Luo (4 shared papers)Xinliang Ming (1 shared paper)Shuo Li (1 shared paper)Mingxia Yu (4 shared papers)Chunzi Liang (4 shared papers)
- Journals
- Cancer Biomarkers (2 papers)Frontiers of Medicine (1 paper)Archives of Medical Science (1 paper)Annals of Clinical Biochemistry International Journal of Laboratory Medicine (1 paper)Phytomedicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Yalan Yu
20 papers receiving 424 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 164
- Hepatology 40
- Molecular Biology 197
- Oncology 50
- Immunology 33
Countries citing papers authored by Yalan Yu
This map shows the geographic impact of Yalan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yalan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yalan Yu more than expected).
Fields of papers citing papers by Yalan Yu
This network shows the impact of papers produced by Yalan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yalan Yu. The network helps show where Yalan Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yalan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 164 | |
| 2 | 2017 | 54 | |
| 3 | 2017 | 52 | |
| 4 | 2017 | 36 | |
| 5 | 2018 | 22 | |
| 6 | 2020 | 17 | |
| 7 | 2022 | 16 | |
| 8 | 2017 | 15 | |
| 9 | 2017 | 15 | |
| 10 | 2020 | 13 | |
| 11 | 2022 | 7 | |
| 12 | 2020 | 5 | |
| 13 | 2022 | 5 | |
| 14 | 2020 | 3 | |
| 15 | 2021 | 2 | |
| 16 | 2018 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2023 | 1 | |
| 20 | 2022 | 1 |
About Yalan Yu
Yalan Yu is a scholar working on Molecular Biology, Hematology, Cancer Research, Infectious Diseases and Genetics, having authored 23 papers that have together received 432 indexed citations. Recurring topics across this work include RNA modifications and cancer (4 papers), Circular RNAs in diseases (3 papers), Acute Myeloid Leukemia Research (3 papers), MicroRNA in disease regulation (3 papers), Cancer-related molecular mechanisms research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (2 papers), Multiple Myeloma Research and Treatments (2 papers) and Long-Term Effects of COVID-19 (2 papers). The work is most often cited by research in Cancer Research (164 citations), Hepatology (40 citations), Molecular Biology (197 citations), Oncology (50 citations) and Immunology (33 citations). Yalan Yu has collaborated with scholars based in China and United States. Frequent co-authors include Jiancheng Tu, Xuelan Zuo, Sanyun Wu, Ping Luo, Xinliang Ming, Shuo Li, Mingxia Yu, Chunzi Liang, Qian Tan and Man Zhu. Their work appears in journals such as Cancer Biomarkers, Frontiers of Medicine, Archives of Medical Science, Annals of Clinical Biochemistry International Journal of Laboratory Medicine and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.